STAAR Surgical Profit Margin 2006-2019 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of March 31, 2019 is 4.44%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.069B $0.124B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.596B 20.52
Align Technology (ALGN) United States $25.810B 69.68
McKesson (MCK) United States $23.745B 9.20
AmerisourceBergen (ABC) United States $16.337B 11.60
Laboratory Of America Holdings (LH) United States $16.194B 15.14
Cooper (COO) United States $14.453B 25.21
Cardinal Health (CAH) United States $13.422B 8.69
DENTSPLY SIRONA (XRAY) United States $12.735B 26.55
Henry Schein (HSIC) United States $10.125B 17.02
West Pharmaceutical Services (WST) United States $8.554B 39.73
Merit Medical Systems (MMSI) United States $3.019B 31.37
CONMED (CNMD) United States $2.268B 36.18
Patterson (PDCO) United States $2.098B 16.58
Atrion (ATRI) United States $1.638B 46.78
Antares Pharma (ATRS) United States $0.457B 0.00
Invacare (IVC) United States $0.226B 0.00
Lifevantage (LFVN) United States $0.164B 21.70
Endologix (ELGX) United States $0.117B 0.00
Pro-Dex (PDEX) United States $0.057B 17.64
Biolase (BIOL) United States $0.040B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.016B 0.00